Clinical Trials: Gastroparesis

Massachusetts

Boston; MGH - Massachusetts General Hospital[*]
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when Administered as a 30 Minute I.V. Infusion to Subjects with Severe Gastroparesis due to Diabetes Mellitus (TZP-101-CL-G004)


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: September 2, 2008 at 2:37:28 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA